CYTOKINETICS INC — Director's Dealing 2017

Sep 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-09-06

Reporting Person: McDowell Caryn Gordon (GC & Chief Compliance Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-06	Common Stock	S	100	$15.0	Disposed	18369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-06	Incentive Stock Option (right to buy)	$6.37	M	5732	Disposed	2025-05-29	Common Stock (5732)	Direct
2017-09-06	Incentive Stock Option (right to buy)	$6.67	M	3067	Disposed	2026-02-23	Common Stock (3067)	Direct
2017-09-06	Non-Qualified Stock Option (right to buy)	$6.67	M	1432	Disposed	2026-02-23	Common Stock (1432)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.